BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17920044)

  • 1. Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors.
    Ohno Y; Hibino H; Lossin C; Inanobe A; Kurachi Y
    Brain Res; 2007 Oct; 1178():44-51. PubMed ID: 17920044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline.
    Su S; Ohno Y; Lossin C; Hibino H; Inanobe A; Kurachi Y
    J Pharmacol Exp Ther; 2007 Feb; 320(2):573-80. PubMed ID: 17071817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel.
    Furutani K; Ohno Y; Inanobe A; Hibino H; Kurachi Y
    Mol Pharmacol; 2009 Jun; 75(6):1287-95. PubMed ID: 19264848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Kir4.1 potassium channels by quinacrine.
    Marmolejo-Murillo LG; Aréchiga-Figueroa IA; Cui M; Moreno-Galindo EG; Navarro-Polanco RA; Sánchez-Chapula JA; Ferrer T; Rodríguez-Menchaca AA
    Brain Res; 2017 May; 1663():87-94. PubMed ID: 28288868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of Kir4.1 channels in spinal cord astrocytes.
    Olsen ML; Higashimori H; Campbell SL; Hablitz JJ; Sontheimer H
    Glia; 2006 Apr; 53(5):516-28. PubMed ID: 16369934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes.
    Kucheryavykh YV; Kucheryavykh LY; Nichols CG; Maldonado HM; Baksi K; Reichenbach A; Skatchkov SN; Eaton MJ
    Glia; 2007 Feb; 55(3):274-81. PubMed ID: 17091490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine.
    Kobayashi T; Washiyama K; Ikeda K
    J Pharmacol Sci; 2006 Nov; 102(3):278-87. PubMed ID: 17072103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanosine promotes the up-regulation of inward rectifier potassium current mediated by Kir4.1 in cultured rat cortical astrocytes.
    Benfenati V; Caprini M; Nobile M; Rapisarda C; Ferroni S
    J Neurochem; 2006 Jul; 98(2):430-45. PubMed ID: 16805837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs.
    Kobayashi T; Washiyama K; Ikeda K
    Neuropsychopharmacology; 2004 Oct; 29(10):1841-51. PubMed ID: 15150531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of fluorescence-based and automated patch clamp-based functional assays for the inward rectifier potassium channel Kir4.1.
    Raphemot R; Kadakia RJ; Olsen ML; Banerjee S; Days E; Smith SS; Weaver CD; Denton JS
    Assay Drug Dev Technol; 2013; 11(9-10):532-43. PubMed ID: 24266659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit.
    Seifert G; Hüttmann K; Binder DK; Hartmann C; Wyczynski A; Neusch C; Steinhäuser C
    J Neurosci; 2009 Jun; 29(23):7474-88. PubMed ID: 19515915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants.
    Takahashi T; Kobayashi T; Ozaki M; Takamatsu Y; Ogai Y; Ohta M; Yamamoto H; Ikeda K
    Neurosci Res; 2006 Feb; 54(2):104-11. PubMed ID: 16310876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake.
    Rivera-Aponte DE; Méndez-González MP; Rivera-Pagán AF; Kucheryavykh YV; Kucheryavykh LY; Skatchkov SN; Eaton MJ
    Neuroscience; 2015 Dec; 310():216-23. PubMed ID: 26404875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.
    Kennard LE; Chumbley JR; Ranatunga KM; Armstrong SJ; Veale EL; Mathie A
    Br J Pharmacol; 2005 Mar; 144(6):821-9. PubMed ID: 15685212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open channel block of Kv3.1 currents by fluoxetine.
    Sung MJ; Ahn HS; Hahn SJ; Choi BH
    J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of K+ currents of outer hair cells in guinea pig cochlea by fluoxetine.
    Bian JT; Yeh JZ; Aistrup GL; Narahashi T; Moore EJ
    Eur J Pharmacol; 2002 Oct; 453(2-3):159-66. PubMed ID: 12398899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review.
    Della Vecchia S; Marchese M; Santorelli FM; Sicca F
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells.
    Hahn SJ; Choi JS; Rhie DJ; Oh CS; Jo YH; Kim MS
    Eur J Pharmacol; 1999 Feb; 367(1):113-8. PubMed ID: 10082273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.